<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02343601</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A00870-47</org_study_id>
    <nct_id>NCT02343601</nct_id>
  </id_info>
  <brief_title>Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery</brief_title>
  <acronym>PANEX3</acronym>
  <official_title>Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery : A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether hemodynamic optimization with
      photoplethysmography (ClearSight, Edwards Lifesciences, Irvine, CA) during colorectal surgery
      could decrease the incidence of perioperative complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients received the photoplethysmography monitoring, but the monitor was blinded in the
      control group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of patients presenting at least one complication after colorectal surgery</measure>
    <time_frame>Up to 28 days after surgery (length of hospital stay)</time_frame>
    <description>Two independent experts defined the presence of complication using an a priori classification.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All complications happening after colorectal surgery</measure>
    <time_frame>Up to 28 days after surgery (length of hospital stay)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Real length of hospital stay</measure>
    <time_frame>Up to 28 days after surgery (length of hospital stay)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative mortality</measure>
    <time_frame>28 days after surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Medico economic evaluation of cost of treatment</measure>
    <time_frame>Up to 28 days after surgery (length of hospital stay)</time_frame>
    <description>Medico economic evaluation of photoplethysmography use will be assessed with a specific unit of measure, using cost of treatment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Polyp of Large Intestine</condition>
  <condition>Colorectal Neoplasms</condition>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group using a hemodynamic standard protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Photoplethysmography group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hemodynamic optimization using Photoplethysmography device (ClearSight, Edwards Lifesciences, Irvine, CA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Photoplethysmography</intervention_name>
    <description>Use Photoplethysmography for hemodynamic optimization during colorectal perioperative period</description>
    <arm_group_label>Photoplethysmography group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt; 18 years

          -  Colorectal surgery

        Exclusion Criteria:

          -  Pregnant women

          -  Black skin

          -  Chronic renal insufficiency (MDRD &lt;30 ml/min)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Lise Fiant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc-Olivier Fischer, MD</last_name>
    <phone>+33 231 064 736</phone>
    <email>fischer-mo@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cathy Gaillard</last_name>
    <phone>+33 231 065 349</phone>
    <email>gaillard-c@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <zip>14 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fischer Marc-Ollivier</last_name>
      <email>fischer-mo@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>Anne-Lise Fiant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2014</study_first_submitted>
  <study_first_submitted_qc>January 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <last_update_submitted>December 3, 2015</last_update_submitted>
  <last_update_submitted_qc>December 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

